These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 17343257
21. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis? Curnow SJ, Pryce K, Modi N, Knight B, Graham EM, Stewart JE, Fortune F, Stanford MR, Murray PI, Wallace GR. Immunol Lett; 2008 Nov 16; 121(1):7-12. PubMed ID: 18706446 [Abstract] [Full Text] [Related]
22. Recurrent aphthous stomatitis in Behçet's disease: clinical features and correlation with systemic disease expression and severity. Krause I, Rosen Y, Kaplan I, Milo G, Guedj D, Molad Y, Weinberger A. J Oral Pathol Med; 1999 May 16; 28(5):193-6. PubMed ID: 10226940 [Abstract] [Full Text] [Related]
23. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease. Sugita S, Kawazoe Y, Imai A, Kawaguchi T, Horie S, Keino H, Takahashi M, Mochizuki M. J Immunol; 2013 Jun 01; 190(11):5799-808. PubMed ID: 23630362 [Abstract] [Full Text] [Related]
24. Does hepcidin play a role in the pathogenesis of aphthae in Behçet's disease and recurrent aphthous stomatitis? Cicek D, Dağlı AF, Aydin S, Baskaya Dogan F, Dertlioğlu SB, Uçak H, Demir B. J Eur Acad Dermatol Venereol; 2014 Nov 01; 28(11):1500-6. PubMed ID: 24341321 [Abstract] [Full Text] [Related]
25. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P. Br J Dermatol; 2006 Oct 01; 155(4):722-8. PubMed ID: 16965421 [Abstract] [Full Text] [Related]
26. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Buño IJ, Huff JC, Weston WL, Cook DT, Brice SL. Arch Dermatol; 1998 Jul 01; 134(7):827-31. PubMed ID: 9681346 [Abstract] [Full Text] [Related]
27. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients. Casas R, Lindau C, Zetterström O, Duchén K. Scand J Immunol; 2008 Sep 01; 68(3):351-61. PubMed ID: 18782262 [Abstract] [Full Text] [Related]
28. Detection, enumeration and characterization of T helper cells secreting type 1 and type 2 cytokines in patients with recurrent aphthous stomatitis. Albanidou-Farmaki E, Markopoulos AK, Kalogerakou F, Antoniades DZ. Tohoku J Exp Med; 2007 Jun 01; 212(2):101-5. PubMed ID: 17548954 [Abstract] [Full Text] [Related]
29. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study. Nanke Y, Kamatani N, Okamoto T, Ogiuchi H, Kotake S. Drugs R D; 2008 Jun 01; 9(6):455-9. PubMed ID: 18989994 [Abstract] [Full Text] [Related]
30. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis. Arabaci T, Kara C, Ciçek Y. J Periodontal Res; 2009 Dec 01; 44(6):718-25. PubMed ID: 19076988 [Abstract] [Full Text] [Related]
31. Mean platelet volume as a predictor in the differentiation of Behçet's disease from recurrent aphthous stomatitis - A single centre, prospective, case-control study. Turan Ç, Metin N, Utlu Z, Tezcan D. Int J Clin Pract; 2021 Nov 01; 75(11):e14866. PubMed ID: 34519145 [Abstract] [Full Text] [Related]
32. Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease. Oh SH, Han EC, Lee JH, Bang D. Clin Exp Dermatol; 2009 Aug 01; 34(6):e208-12. PubMed ID: 19549229 [Abstract] [Full Text] [Related]
33. The association between total antioxidant status and oxidative stress in Behçet's disease. Sepici-Dinçel A, Ozkan Y, Yardim-Akaydin S, Kaymak-Karataş G, Onder M, Simşek B. Rheumatol Int; 2006 Sep 01; 26(11):1005-9. PubMed ID: 16715292 [Abstract] [Full Text] [Related]
34. Differential expression of suppressor of cytokine signalling proteins in Behçet's disease. Hamedi M, Bergmeier LA, Hagi-Pavli E, Vartoukian SR, Fortune F. Scand J Immunol; 2014 Nov 01; 80(5):369-76. PubMed ID: 25207681 [Abstract] [Full Text] [Related]
35. Evaluation of cytokine expressions in patients with recurrent aphthous stomatitis: A systematic review and meta-analysis. Teng F, Jin Q. PLoS One; 2024 Nov 01; 19(6):e0305355. PubMed ID: 38861558 [Abstract] [Full Text] [Related]
36. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations. Pekiner FN, Aytugar E, Demirel GY, Borahan MO. J Oral Pathol Med; 2012 Jan 01; 41(1):73-9. PubMed ID: 21736625 [Abstract] [Full Text] [Related]
37. Chemokines and chemokine receptors in Behçet's disease. Li Z, Cheng L, Zhan H, Li Y. Front Immunol; 2023 Jan 01; 14():1109147. PubMed ID: 36742301 [Abstract] [Full Text] [Related]
38. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease. Nagafuchi H, Takeno M, Yoshikawa H, Kurokawa MS, Nara K, Takada E, Masuda C, Mizoguchi M, Suzuki N. Clin Exp Immunol; 2005 Feb 01; 139(2):363-70. PubMed ID: 15654836 [Abstract] [Full Text] [Related]
39. Changes in Th1/Th2-related cytokine expression in the saliva of patients with recurrent aphthous stomatitis before and after prednisone treatment. Deng Y, Yao Y, Du G, Liu W. Clin Oral Investig; 2022 Jan 01; 26(1):1089-1093. PubMed ID: 35043219 [Abstract] [Full Text] [Related]
40. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease. Shimizu J, Izumi T, Arimitsu N, Fujiwara N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Takai K, Suzuki N. Clin Exp Rheumatol; 2012 Jan 01; 30(3 Suppl 72):S35-9. PubMed ID: 22935165 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]